AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
EFFECT OF NORMALIZATION OF HEMATOCRIT ON BRAIN CIRCULATION AND METABOLISM IN HEMODIALYSIS-PATIENTS
Authors: METRY G WIKSTROM B VALIND S DANIELSON BG
Citation: G. Metry et al., EFFECT OF NORMALIZATION OF HEMATOCRIT ON BRAIN CIRCULATION AND METABOLISM IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1132-1132
THE REQUIRED DOSE OF ERYTHROPOIETIN DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY
Authors: LINDE T SANDHAGEN B WIKSTROM B DANIELSON BG
Citation: T. Linde et al., THE REQUIRED DOSE OF ERYTHROPOIETIN DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY, Nephrology, dialysis, transplantation, 12(11), 1997, pp. 2375-2379
ASSESSMENT OF ERYTHROPOIESIS FOLLOWING RENAL-TRANSPLANTATION
Authors: BESHARA S BIRGEGARD G GOCH J WAHLBERG J WIKSTROM B DANIELSON BG
Citation: S. Beshara et al., ASSESSMENT OF ERYTHROPOIESIS FOLLOWING RENAL-TRANSPLANTATION, European journal of haematology, 58(3), 1997, pp. 167-173
EFFECTS OF EXTRACORPOREAL HEMAPHERESIS THERAPY ON BLOOD RHEOLOGY
Authors: FADUL JEM LINDE T SANDHAGEN B WIKSTROM B DANIELSON BG
Citation: Jem. Fadul et al., EFFECTS OF EXTRACORPOREAL HEMAPHERESIS THERAPY ON BLOOD RHEOLOGY, Journal of clinical apheresis, 12(4), 1997, pp. 183-186
ANEMIA ASSOCIATED WITH ADVANCED PROSTATIC ADENOCARCINOMA - EFFECTS OFRECOMBINANT-HUMAN-ERYTHROPOIETIN
Authors: BESHARA S LETOCHA H LINDE T WIKSTROM B SANDHAGEN B NILSSON S DANIELSON BG
Citation: S. Beshara et al., ANEMIA ASSOCIATED WITH ADVANCED PROSTATIC ADENOCARCINOMA - EFFECTS OFRECOMBINANT-HUMAN-ERYTHROPOIETIN, The Prostate, 31(3), 1997, pp. 153-160
EFFECTS OF LDL APHERESIS ON BLOOD RHEOLOGY IN 2 PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: FADUL JEM SANDHAGEN B LINDE T VESSBY B WIKSTROM B DANIELSON BG
Citation: Jem. Fadul et al., EFFECTS OF LDL APHERESIS ON BLOOD RHEOLOGY IN 2 PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, Blood purification, 15(3), 1997, pp. 182-187
PROPORTIONAL CHANGES IN BODY-FLUID WITH HEMODIALYSIS EVALUATED BY DUAL-ENERGY X-RAY ABSORPTIOMETRY AND TRANSTHORACIC BIOIMPEDANCE WITH PARTICULAR EMPHASIS ON THE THORACIC REGION
Authors: METRY G MALLMIN H WIKSTROM B DANIELSON BG
Citation: G. Metry et al., PROPORTIONAL CHANGES IN BODY-FLUID WITH HEMODIALYSIS EVALUATED BY DUAL-ENERGY X-RAY ABSORPTIOMETRY AND TRANSTHORACIC BIOIMPEDANCE WITH PARTICULAR EMPHASIS ON THE THORACIC REGION, Artificial organs, 21(9), 1997, pp. 969-976
TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH LOW-DENSITY-LIPOPROTEIN APHERESIS - A 4 YEAR FOLLOW-UP-STUDY
Authors: FADUL JEM VESSBY B WIKSTROM B DANIELSON BG
Citation: Jem. Fadul et al., TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH LOW-DENSITY-LIPOPROTEIN APHERESIS - A 4 YEAR FOLLOW-UP-STUDY, Artificial organs, 21(5), 1997, pp. 364-368
LUNG DENSITY FOR ASSESSMENT OF HYDRATION STATUS IN HEMODIALYSIS-PATIENTS USING THE COMPUTED TOMOGRAPHIC DENSITOMETRY TECHNIQUE
Authors: METRY G WEGENIUS G WIKSTROM B KALLSKOG V HANSELL P LINDGREN PG HEDENSTROM H DANIELSON BG
Citation: G. Metry et al., LUNG DENSITY FOR ASSESSMENT OF HYDRATION STATUS IN HEMODIALYSIS-PATIENTS USING THE COMPUTED TOMOGRAPHIC DENSITOMETRY TECHNIQUE, Kidney international, 52(6), 1997, pp. 1635-1644
COMPUTED TOMOGRAPHIC MEASUREMENT OF LUNG DENSITY - CHANGES IN LUNG WATER WITH HEMODIALYSIS
Authors: METRY G WEGENIUS G HEDENSTROM H WIKSTROM B DANIELSON BG
Citation: G. Metry et al., COMPUTED TOMOGRAPHIC MEASUREMENT OF LUNG DENSITY - CHANGES IN LUNG WATER WITH HEMODIALYSIS, Nephron, 75(4), 1997, pp. 394-401
GENDER AND AGE-DIFFERENCES IN TRANSTHORACIC BIOIMPEDANCE
Authors: METRY G WIKSTROM B LINDE T DANIELSON BG
Citation: G. Metry et al., GENDER AND AGE-DIFFERENCES IN TRANSTHORACIC BIOIMPEDANCE, Acta Physiologica Scandinavica, 161(2), 1997, pp. 171-175
THE REQUIRED DOSE OF ERYTHROPOIETIN (EPO) DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY
Authors: LINDE T SANDHAGEN B WIKSTROM B DANIELSON BG
Citation: T. Linde et al., THE REQUIRED DOSE OF ERYTHROPOIETIN (EPO) DURING RENAL ANEMIA TREATMENT IS RELATED TO THE DEGREE OF IMPAIRMENT IN ERYTHROCYTE DEFORMABILITY, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1205-1205
DECREASED BLOOD-VISCOSITY AND SERUM LEVELS OF ERYTHROPOIETIN AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPINE OR METOPROLOL - RESULTS OF A CROSS-OVER STUDY
Authors: LINDE T SANDHAGEN B HAGG A MORLIN C DANIELSON BG
Citation: T. Linde et al., DECREASED BLOOD-VISCOSITY AND SERUM LEVELS OF ERYTHROPOIETIN AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPINE OR METOPROLOL - RESULTS OF A CROSS-OVER STUDY, Journal of human hypertension, 10(3), 1996, pp. 199-205
REDUCTION OF PLASMA-FIBRINOGEN, IMMUNOGLOBULIN-G, AND IMMUNOGLOBULIN-M CONCENTRATIONS BY IMMUNOADSORPTION THERAPY WITH TRYPTOPHAN AND PHENYLALANINE ADSORBENTS
Authors: FADUL JEM DANIELSON BG WIKSTROM B
Citation: Jem. Fadul et al., REDUCTION OF PLASMA-FIBRINOGEN, IMMUNOGLOBULIN-G, AND IMMUNOGLOBULIN-M CONCENTRATIONS BY IMMUNOADSORPTION THERAPY WITH TRYPTOPHAN AND PHENYLALANINE ADSORBENTS, Artificial organs, 20(9), 1996, pp. 986-990
IMPROVED FLOW PROPERTIES OF BLOOD AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPIN OR METOPROLOL
Authors: LINDE T SANDHAGEN B HAGG A MORLIN C DANIELSON BG
Citation: T. Linde et al., IMPROVED FLOW PROPERTIES OF BLOOD AFTER ANTIHYPERTENSIVE TREATMENT WITH AMLODIPIN OR METOPROLOL, Kidney international, 49(3), 1996, pp. 924-924
RENAL ANEMIA TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN INCREASES CARDIAC-OUTPUT IN PATIENTS WITH ISCHEMIC-HEART-DISEASE
Authors: LINDE T WIKSTROM B ANDERSSON LG DANIELSON BG
Citation: T. Linde et al., RENAL ANEMIA TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN INCREASES CARDIAC-OUTPUT IN PATIENTS WITH ISCHEMIC-HEART-DISEASE, Scandinavian journal of urology and nephrology, 30(2), 1996, pp. 115-120
SERUM ERYTHROPOIETIN AND ERYTHROPOIESIS DURING 6 YEARS AFTER KIDNEY-TRANSPLANTATION
Authors: GOCH J BORGEGARD G WIKSTROM B BACKMAN U WADSTROM J DANIELSON BG
Citation: J. Goch et al., SERUM ERYTHROPOIETIN AND ERYTHROPOIESIS DURING 6 YEARS AFTER KIDNEY-TRANSPLANTATION, Nephron, 74(4), 1996, pp. 687-693
IRON-ABSORPTION IN PATIENTS WITH CHRONIC UREMIA ON MAINTENANCE HEMODIALYSIS AND IN HEALTHY-VOLUNTEERS MEASURED WITH A SIMPLE ORAL IRON LOADTEST
Authors: GOCH J BIRGEGARD G DANIELSON BG WIKSTROM B
Citation: J. Goch et al., IRON-ABSORPTION IN PATIENTS WITH CHRONIC UREMIA ON MAINTENANCE HEMODIALYSIS AND IN HEALTHY-VOLUNTEERS MEASURED WITH A SIMPLE ORAL IRON LOADTEST, Nephron, 73(3), 1996, pp. 403-406
PHARMACOKINETICS OF IRON(III)-HYDROXIDE SUCROSE COMPLEX AFTER A SINGLE INTRAVENOUS DOSE IN HEALTHY-VOLUNTEERS
Authors: DANIELSON BG SALMONSON T DERENDORF H GEISSER P
Citation: Bg. Danielson et al., PHARMACOKINETICS OF IRON(III)-HYDROXIDE SUCROSE COMPLEX AFTER A SINGLE INTRAVENOUS DOSE IN HEALTHY-VOLUNTEERS, Arzneimittel-Forschung, 46(6), 1996, pp. 615-621
TREATMENT OF ERYTHROPOIETIN-RESISTANT ANEMIA WITH DESFERRIOXAMINE IN PATIENTS ON HEMOFILTRATION
Authors: GOCH J BIRGEGARD G DANIELSON BG WIKSTROM B
Citation: J. Goch et al., TREATMENT OF ERYTHROPOIETIN-RESISTANT ANEMIA WITH DESFERRIOXAMINE IN PATIENTS ON HEMOFILTRATION, European journal of haematology, 55(2), 1995, pp. 73-77
TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45
Authors: LINDE T RONQUIST G SANDHAGEN B WIKSTROM B FRITHZ G PETTERSSON L DANIELSON BG
Citation: T. Linde et al., TREATMENT OF RENAL ANEMIA WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN RESULTS IN DECREASED RED-CELL UPTAKE OF CA-45, Nephron, 68(4), 1994, pp. 419-426
REDUCED OXYGEN-AFFINITY CONTRIBUTES TO IMPROVED OXYGEN RELEASING CAPACITY DURING ERYTHROPOIETIN TREATMENT OF RENAL ANEMIA
Authors: LINDE T SANDHAGEN B BRATTEBY LE DEVERDIER CH DANIELSON BG WIKSTROM B
Citation: T. Linde et al., REDUCED OXYGEN-AFFINITY CONTRIBUTES TO IMPROVED OXYGEN RELEASING CAPACITY DURING ERYTHROPOIETIN TREATMENT OF RENAL ANEMIA, Nephrology, dialysis, transplantation, 8(6), 1993, pp. 524-529
BLOOD-VISCOSITY AND PERIPHERAL VASCULAR-RESISTANCE IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION
Authors: LINDE T SANDHAGEN B HAGG A MORLIN C WIKSTROM B DANIELSON BG
Citation: T. Linde et al., BLOOD-VISCOSITY AND PERIPHERAL VASCULAR-RESISTANCE IN PATIENTS WITH UNTREATED ESSENTIAL-HYPERTENSION, Journal of hypertension, 11(7), 1993, pp. 731-736
COMPLEMENT ACTIVATION DURING TRYPTOPHAN IMMUNOADSORPTION TREATMENT
Authors: ALARABI AA NILSSON B NILSSON U WIKSTROM B DANIELSON BG
Citation: Aa. Alarabi et al., COMPLEMENT ACTIVATION DURING TRYPTOPHAN IMMUNOADSORPTION TREATMENT, Artificial organs, 17(9), 1993, pp. 782-786
PRETRANSPLANTATION IMMUNOADSORPTION THERAPY IN PATIENTS IMMUNIZED WITH HUMAN LYMPHOCYTE ANTIGEN - EFFECT OF TREATMENT AND 3 YEARS CLINICAL FOLLOW-UP OF GRAFTS
Authors: ALARABI AA WIKSTROM B BACKMAN U DANIELSON BG TUFVESSON G SJOBERG O
Citation: Aa. Alarabi et al., PRETRANSPLANTATION IMMUNOADSORPTION THERAPY IN PATIENTS IMMUNIZED WITH HUMAN LYMPHOCYTE ANTIGEN - EFFECT OF TREATMENT AND 3 YEARS CLINICAL FOLLOW-UP OF GRAFTS, Artificial organs, 17(8), 1993, pp. 702-707
Risultati: 1-25 | 26-26